Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Mcilraith M, Hu C, Edwards C, Birbara C, Mease P (2016)
Publication Type: Conference contribution
Publication year: 2016
Book Volume: 43
Pages Range: 1169-1169
Journal Issue: 6
APA:
Gladman, D., Kavanaugh, A., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Cutolo, M.,... Mease, P. (2016). Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials. (pp. 1169-1169).
MLA:
Gladman, Dafna, et al. "Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials." 2016. 1169-1169.
BibTeX: Download